EU drug agency concludes that AstraZeneca benefits outweigh the risks

Author: Adam Button | Category: News

But agency says it cannot definitively rule out a like to blood clots

  • Remains important to keep track of all side effects
  • Will continue to study possible links to blood clots
This is not the definitive kind of 'this is safe' ruling we'd all like.

Invest in yourself. See our forex education hub.
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose